| Term 
 | Definition 
 
        | inhibits tyrosine hydroxylase |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: orthostatic hypertension and sedation *RARELY USED* |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks uptake NE/D thru VMAT channels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TX: Hypertension, experimentally used |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: arrhythmia, psychoitc depression, nasal congestion, dizziness, TCP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | concentrates in vessels and displaces NE/D |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | concentrates in vessels and displaces NE/D |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: inhibits cardiac nerves and leads to hypotension during exercise, Kidney disease, apnea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks reuptake of by NET, DAT, inhibit MAO, and displace transmitters from vesicles |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: hypertension, Tourettes, seizures, psychosis, fatigue, loss of appetite, addiction |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | TX: Allergic rhinitis, nasal congestion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | releases stored catecholamines |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE:A fib, ischemia, hypertension, tachycardia, rebound congestion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits NET reuptake of catecholamines |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits NET reuptake of catecholamines |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits NET reuptake of catecholamines |  | 
        |  | 
        
        | Term 
 
        | MAOI's- Phenelzine, Iproniazid |  | Definition 
 
        | inhibit degradation of catecholamines |  | 
        |  | 
        
        | Term 
 
        | MAOI's- Phenelzine, Iproniazid |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: hypertension, bardycardia mediated vagal reflux, |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetrahydrozoline, Oxymetazoline |  | Definition 
 
        | Visine and Afrin Trade names |  | 
        |  | 
        
        | Term 
 
        | Tetrahydrozoline, Oxymetazoline |  | Definition 
 
        | Opthalmic hyperemia, nasal congestion |  | 
        |  | 
        
        | Term 
 
        | Tetrahydrozoline, Oxymetazoline, Phenylephrine |  | Definition 
 
        | AE: arrhythmia, hypertension, headache, rebound congestion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A-2 agonist inhibiting sympathetic outflow from CNS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A-2 agonist inhibiting sympathetic outflow from CNS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A-2 Agonist inhibiting sympathetic outflow from CNS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TX: opoid withdrawl, cancer pain, hypertension with renal disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treatment of Hypertension during pregnancy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: hepatotoxicity, AI hemolytic anemia, and DO NOT USE WITH MAOI |  | 
        |  | 
        
        | Term 
 
        | Metaproterenol, Albuterol, Salmeterol, terbutaline |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Metaproterenol and Albuterol |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | TX: long term asthma treatment and COPD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reduce premature uterine contractions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A-1/2  irreversible antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A-1/2 reversible antagonist |  | 
        |  | 
        
        | Term 
 
        | Phentolamine, Phenoxybenzamine |  | Definition 
 
        | TX: Pheochromocytoma leading to hypertension |  | 
        |  | 
        
        | Term 
 
        | Phentolamine, Phenoxybenzamine |  | Definition 
 
        | AE: hypotension, lack of ejaculation, dry eyes, seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used in patients with MAO'I's who eat foods with large amounts of tyramine containing foods which lead to displaced NE and hypertension |  | 
        |  | 
        
        | Term 
 
        | Prazosin, Terazosinm Doxazosin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Prazosin, Terazosinm Doxazosin |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | A1 antagonist of GU smooth muscle |  | 
        |  | 
        
        | Term 
 
        | Prazosin, Terazosin, Doxazosin |  | Definition 
 
        | AE: Pancreatitis, hepatotoxic, SLE, postural hypotension with first dose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A-2 antagonist which leads to increased NE, and increased B1 receptors and peripheral vascular receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Propranolol, Nadolol, Timolol |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Propranolol, Nadolol, Timolol |  | Definition 
 
        | Hypertension, Angina, MI, CHF |  | 
        |  | 
        
        | Term 
 
        | Timolol, levobunolol and carteolol |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: impotence, asthma, bradycardia, AV block, decreased libido |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | block a1 b1 and b2 receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | AE: same as Betablockers but Hepatotoxic as well |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | partial b agonists (1st both b1/b2, 2nd only b2) |  | 
        |  | 
        
        | Term 
 
        | Atenolol, metoprolol, esmolol (short), betaxolol |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Atenolol, metoprolol, esmolol (short), betaxolol |  | Definition 
 
        | Tx: hypertension, angina, heart failure |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase SM contraction, GU contraction, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits sympathetic release in CNS, decreased insulin release, platelets aggregate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase heart rate, strength, AV conduction increases renin release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | relaxes smooth muscle, glycogen breakdown and glucose release |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |